Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01857973 · ClinicalTrials.gov registry record · NA
Overnight Closed Loop Study in U.S.
A NA study, sponsored by Medtronic MiniMed.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT01857973: Completed NA study, sponsored by Medtronic MiniMed.
NCT01857973 is a NA study that has completed, run by Medtronic MiniMed. The registered enrollment target is 78 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01857973, a NA study, has completed, sponsored by Medtronic MiniMed.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
This is a multicenter feasibility study. Up to 85 subjects will be enrolled in the study. The goal of the study is to demonstrate that the Hybrid Closed Loop (HCL) System is safe to be used in an even larger study outside of hospital.
Interventions
- DEVICE Hybrid Closed Loop
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2013-06 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01857973
The ClinicalTrials.gov registry entry for NCT01857973 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic MiniMed, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hybrid Closed Loop is the first listed.
NCT01857973 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01857973 about?
NCT01857973 is a clinical study titled "Overnight Closed Loop Study in U.S.". This is a multicenter feasibility study. Up to 85 subjects will be enrolled in the study. The goal of the study is to demonstrate that the Hybrid Closed Loop (HCL) System is safe to be used in an even larger study outside of hospital.
What is the current status of trial NCT01857973?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2013-06. Estimated completion is 2016-10.
What interventions are being tested in trial NCT01857973?
The interventions under investigation include: Hybrid Closed Loop (DEVICE).
Who is sponsoring clinical trial NCT01857973?
This trial is sponsored by Medtronic MiniMed, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.